Related Experiment Video
Updated: Sep 14, 2025
Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
A CRISPR/Cas9 knockout model for AADC deficiency reveals structural loop3 instability as a key driver of catalytic
Sema Kalkan Uçar1, Cem Yıldırım2, Thomas Opladen3
1Department of Pediatrics, Division of Metabolism and Nutrition, Ege University Medical Faculty, Izmir, Türkiye.
Abstract:
The CRISPR-Cas9 dopa decarboxylase (DDC) gene knockout SH-SY5Y model for aromatic L-amino acid decarboxylase (AADC) deficiency provides a valuable neuronal platform for functional and structural investigation of pathogenic variants. In their study, Bertoldi et al. successfully recapitulate the biochemical and metabolic hallmarks of AADC deficiency using the AADC catalytic variants R347Q and L353P. Their combined structural and cellular approach identifies loop3 dynamics as a critical determinant of enzymatic dysfunction. This model may pave the way for the development of precision therapies.
Insights
Researchers developed a CRISPR-Cas9 knockout model of aromatic L-amino acid decarboxylase (AADC) deficiency. This neuronal model successfully mimics the disease, identifying loop3 dynamics as key to enzymatic dysfunction and paving the way for new therapies.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare metabolic disorder affecting neurotransmitter synthesis.
- Existing models may not fully capture the complexity of AADC deficiency's biochemical and cellular hallmarks.
Purpose of the Study:
- To establish a CRISPR-Cas9 induced dopa decarboxylase (DDC) gene knockout SH-SY5Y neuronal model for studying AADC deficiency.
- To investigate the functional and structural impact of pathogenic AADC variants using this novel model.
- To identify key molecular determinants of enzymatic dysfunction in AADC deficiency.
Main Methods:
- CRISPR-Cas9 gene editing to create DDC knockout SH-SY5Y cells.
- Expression and characterization of specific AADC catalytic variants (R347Q, L353P).
- Combined structural and cellular assays to assess enzymatic activity and cellular phenotypes.
Main Results:
- The DDC knockout SH-SY5Y model successfully recapitulated the biochemical and metabolic characteristics of AADC deficiency.
- The study identified specific AADC catalytic variants (R347Q, L353P) that mimic disease phenotypes.
- Enzymatic dysfunction was critically linked to the dynamics of loop3 within the AADC enzyme.
Conclusions:
- The developed CRISPR-Cas9 DDC knockout SH-SY5Y model serves as a valuable platform for AADC deficiency research.
- Understanding loop3 dynamics offers insights into the molecular mechanisms underlying AADC enzymatic dysfunction.
- This research may facilitate the development of targeted precision therapies for AADC deficiency.
